NCT01880515 2025-05-11
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Instituto Nacional de Cancerologia de Mexico
Phase 2 Completed
Instituto Nacional de Cancerologia de Mexico
Cyprus University of Technology
Asan Medical Center
Vyne Therapeutics Inc.
Impaqtt Foundation
British Columbia Cancer Agency
Memorial Sloan Kettering Cancer Center
Amgen
Mt. Sinai Medical Center, Miami